Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Edwards Lifesciences Corp (NYSE: EW) closed the day trading at $90.57 down -0.72% from the previous closing price of $91.23. In other words, the price has decreased by -$0.72 from its previous closing price. On the day, 1.5 million shares were traded. EW stock price reached its highest trading level at $92.11 during the session, while it also had its lowest trading level at $90.61.
Ratios:
For a better understanding of EW, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 32.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 201.11. For the most recent quarter (mrq), Quick Ratio is recorded 2.67 and its Current Ratio is at 3.75. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on May 30, 2024, initiated with a Buy rating and assigned the stock a target price of $107.
On May 22, 2024, Citigroup Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $98 to $105.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 20 ’24 when Ullem Scott B. sold 5,625 shares for $87.51 per share. The transaction valued at 492,258 led to the insider holds 30,561 shares of the business.
Lippis Daniel J. sold 535 shares of EW for $48,150 on Jun 20 ’24. The CVP, JAPAC now owns 23,513 shares after completing the transaction at $90.00 per share. On Jun 12 ’24, another insider, BOBO DONALD E JR, who serves as the CVP,Strategy/Corp Development of the company, sold 5,000 shares for $87.54 each. As a result, the insider received 437,696 and left with 46,936 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EW now has a Market Capitalization of 54884810752 and an Enterprise Value of 53954908160. As of this moment, Edwards’s Price-to-Earnings (P/E) ratio for their current fiscal year is 38.93, and their Forward P/E ratio for the next fiscal year is 29.16. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.88 while its Price-to-Book (P/B) ratio in mrq is 7.67. Its current Enterprise Value per Revenue stands at 8.783 whereas that against EBITDA is 28.1.
Stock Price History:
The Beta on a monthly basis for EW is 1.11, which has changed by 0.006853819 over the last 52 weeks, in comparison to a change of 0.25510752 over the same period for the S&P500. Over the past 52 weeks, EW has reached a high of $96.12, while it has fallen to a 52-week low of $60.57. The 50-Day Moving Average of the stock is 2.99%, while the 200-Day Moving Average is calculated to be 12.88%.
Shares Statistics:
Over the past 3-months, EW traded about 2.87M shares per day on average, while over the past 10 days, EW traded about 4069730 shares per day. A total of 601.10M shares are outstanding, with a floating share count of 592.96M. Insiders hold about 1.60% of the company’s shares, while institutions hold 83.61% stake in the company. Shares short for EW as of 1718323200 were 8186141 with a Short Ratio of 2.85, compared to 1715731200 on 8002174. Therefore, it implies a Short% of Shares Outstanding of 8186141 and a Short% of Float of 1.37.
Earnings Estimates
The current rating of Edwards Lifesciences Corp (EW) is the result of assessments by 26.0 analysts actively engaged in evaluating its market dynamics.On average, analysts expect EPS of $0.69 for the current quarter, with a high estimate of $0.71 and a low estimate of $0.67, while EPS last year was $0.66. The consensus estimate for the next quarter is $0.69, with high estimates of $0.71 and low estimates of $0.66.
Analysts are recommending an EPS of between $2.8 and $2.66 for the fiscal current year, implying an average EPS of $2.76. EPS for the following year is $3.11, with 30.0 analysts recommending between $3.43 and $2.74.
Revenue Estimates
25 analysts predict $1.65B in revenue for the current quarter. It ranges from a high estimate of $1.67B to a low estimate of $1.6B. As of the current estimate, Edwards Lifesciences Corp’s year-ago sales were $1.5BFor the next quarter, 25 analysts are estimating revenue of $1.62B. There is a high estimate of $1.7B for the next quarter, whereas the lowest estimate is $1.59B.
A total of 32 analysts have provided revenue estimates for EW’s current fiscal year. The highest revenue estimate was $6.62B, while the lowest revenue estimate was $6.48B, resulting in an average revenue estimate of $6.56B. In the same quarter a year ago, actual revenue was $6BBased on 32 analysts’ estimates, the company’s revenue will be $7.14B in the next fiscal year. The high estimate is $7.36B and the low estimate is $6.02B.
